Mark Baer
- PcrV antibody prophylaxis in combination with antibiotic therapy reduces lung injury and improves survival in Pseudomonas aeruginosa infected miceBy Yuanlin Song, Mark Baer, Ramya Srinivasan, Juliana Lima, Geoffrey Yarranton, Christopher Bebbington and Susan LynchYuanlin Song1Department of Pulmonary Medicine, Zhongshan Hospital, Shanghai, ChinaMark Baer2KaloBios Pharmaceutical, Inc., Kalobiso Pharmaceutical, Inc., San Francisco, CA, United StatesRamya Srinivasan3Gasteroenterology, University of California, San Francisco, San Francisco, CA, United StatesJuliana Lima4Anesthesia and Perioperative Care, UCSF, San Francisco, CA, United StatesGeoffrey Yarranton2KaloBios Pharmaceutical, Inc., Kalobiso Pharmaceutical, Inc., San Francisco, CA, United StatesChristopher Bebbington2KaloBios Pharmaceutical, Inc., Kalobiso Pharmaceutical, Inc., San Francisco, CA, United StatesSusan Lynch3Gasteroenterology, University of California, San Francisco, San Francisco, CA, United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.